Cephalon Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CEPHALON, and what generic alternatives to CEPHALON drugs are available?
CEPHALON has eight approved drugs.
There are fifteen US patents protecting CEPHALON drugs.
There are two hundred and thirty-eight patent family members on CEPHALON drugs in thirty-five countries and fourteen supplementary protection certificates in five countries.
Summary for Cephalon
International Patents: | 238 |
US Patents: | 15 |
Tradenames: | 8 |
Ingredients: | 6 |
NDAs: | 8 |
Patent Litigation for Cephalon: | See patent lawsuits for Cephalon |
PTAB Cases with Cephalon as patent owner: | See PTAB cases with Cephalon as patent owner |
Drugs and US Patents for Cephalon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cephalon | TREANDA | bendamustine hydrochloride | POWDER;IV (INFUSION) | 022249-002 | May 1, 2009 | AP | RX | Yes | Yes | 8,883,836*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Cephalon | TREANDA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 022249-004 | Sep 13, 2013 | DISCN | Yes | No | 8,344,006*PED | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Cephalon | FENTANYL | fentanyl citrate | TROCHE/LOZENGE;ORAL | 020195-007 | Oct 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Cephalon | PROVIGIL | modafinil | TABLET;ORAL | 020717-001 | Dec 24, 1998 | AB | RX | Yes | No | 7,297,346*PED | ⤷ Sign Up | ⤷ Sign Up | |||
Cephalon | FENTORA | fentanyl citrate | TABLET;BUCCAL, SUBLINGUAL | 021947-004 | Sep 25, 2006 | RX | Yes | No | 8,092,832 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Cephalon | TREANDA | bendamustine hydrochloride | POWDER;IV (INFUSION) | 022249-001 | Mar 20, 2008 | AP | RX | Yes | Yes | 8,436,190*PED | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cephalon
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cephalon | FENTORA | fentanyl citrate | TABLET;BUCCAL, SUBLINGUAL | 021947-006 | Mar 2, 2007 | 6,974,590 | ⤷ Sign Up |
Cephalon | TRISENOX | arsenic trioxide | INJECTABLE;INJECTION | 021248-002 | Oct 13, 2017 | 8,273,379 | ⤷ Sign Up |
Cephalon | NUVIGIL | armodafinil | TABLET;ORAL | 021875-003 | Jun 15, 2007 | 7,132,570*PED | ⤷ Sign Up |
Cephalon | FENTORA | fentanyl citrate | TABLET;BUCCAL, SUBLINGUAL | 021947-002 | Sep 25, 2006 | 8,728,441 | ⤷ Sign Up |
Cephalon | GABITRIL | tiagabine hydrochloride | TABLET;ORAL | 020646-004 | Sep 30, 1997 | 5,958,951 | ⤷ Sign Up |
Cephalon | TRISENOX | arsenic trioxide | INJECTABLE;INJECTION | 021248-001 | Sep 25, 2000 | 6,982,096 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CEPHALON drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 25 mg/vial and 100 mg/vial | ➤ Subscribe | 2013-06-04 |
➤ Subscribe | Buccal Tablets | 0.1 mg, 0.2 mg, 0.3 mg, 0.4 mg, 0.6 mg and 0.8 mg | ➤ Subscribe | 2007-11-13 |
➤ Subscribe | Tablets | 12 mg and 16 mg | ➤ Subscribe | 2014-01-24 |
➤ Subscribe | Tablets | 100 mg and 200 mg | ➤ Subscribe | 2009-09-11 |
➤ Subscribe | Lozenges | 0.4 mg | ➤ Subscribe | 2004-10-06 |
➤ Subscribe | Lozenges | 0.8 mg, 1.2 mg and 1.6 mg | ➤ Subscribe | 2004-11-22 |
➤ Subscribe | Injection | 1 mg/mL | ➤ Subscribe | 2015-08-11 |
➤ Subscribe | Injection | 90 mg/mL, 0.5 mL and 2 mL in single-dose vials | ➤ Subscribe | 2014-06-19 |
➤ Subscribe | Tablets | 2 mg and 4 mg | ➤ Subscribe | 2005-02-01 |
➤ Subscribe | Tablets | 50 mg, 150 mg and 250 mg | ➤ Subscribe | 2009-07-24 |
➤ Subscribe | Lozenges | 0.2 mg | ➤ Subscribe | 2004-10-29 |
➤ Subscribe | Lozenges | 0.6 mg | ➤ Subscribe | 2004-12-20 |
International Patents for Cephalon Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Taiwan | 200611686 | ⤷ Sign Up |
China | 102078305 | ⤷ Sign Up |
New Zealand | 556435 | ⤷ Sign Up |
Egypt | 24849 | ⤷ Sign Up |
Taiwan | 200419175 | ⤷ Sign Up |
China | 1901890 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cephalon Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0901368 | C300523 | Netherlands | ⤷ Sign Up | PRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006 |
0836511 | 122006000022 | Germany | ⤷ Sign Up | PRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126 |
1635783 | C300653 | Netherlands | ⤷ Sign Up | PRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906 |
0975367 | 122011000009 | Germany | ⤷ Sign Up | PRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831 |
1769785 | C300522 | Netherlands | ⤷ Sign Up | PRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006 |
0836511 | CA 2006 00019 | Denmark | ⤷ Sign Up | PRODUCT NAME: FENTANYL HYDROCHLORID |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.